Cervical Cancer Stage IA1

• Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
• Cervical/vaginal cytologic exam annually as indicated
• Consider complete blood count (CBC), blood urea nitrogen (BUN), creatinine every 6 months or as indicated
• Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
• Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
• Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation

Cervical Cancer Stage IA2, IB1, IIA1

• Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
• Cervical/vaginal cytologic exam annually as indicated
• Consider CBC, BUN, creatinine every 6 months or as indicated
• Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
• Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
• Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation

Cervical Cancer Stage IB2, IIA2, IIB, IIIA, IIIB, IVA

• Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
• Cervical/vaginal cytologic exam annually as indicated
• Consider CBC, BUN, creatinine every 6 months or as indicated
• Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease  
  • At 3-6 months posttreatment completion, the following may be performed:
    • Stage IB2: Whole body PET/CT
    • Stage II-IV: Whole body PET/CT (preferred), CT with contrast of the chest, abdomen or pelvis, or MRI with contrast of the pelvis (optional)
• Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants) 
• Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation

Metastatic Cervical Cancer

• Follow-up visit every 3-6 months x 2 years, then every 6-12 months x 3-5 years, then annually
• Cervical/vaginal cytologic exam annually as indicated
• Consider CBC, BUN, creatinine every 6 months or as indicated
• Imaging should be based on patient’s symptoms and concern for metastatic or recurrent disease
• Educate patient on potential recurrence symptoms, effects of treatment, periodic self-examinations, and sexual health (eg use of vaginal dilator, vaginal moisturizers/lubricants)
• Counsel patient on exercise, obesity, nutrition, lifestyle and smoking cessation